These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 17690183)
1. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. Leroy K; Bretteville A; Schindowski K; Gilissen E; Authelet M; De Decker R; Yilmaz Z; Buée L; Brion JP Am J Pathol; 2007 Sep; 171(3):976-92. PubMed ID: 17690183 [TBL] [Abstract][Full Text] [Related]
2. Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology. Leroy K; Ando K; Héraud C; Yilmaz Z; Authelet M; Boeynaems JM; Buée L; De Decker R; Brion JP J Alzheimers Dis; 2010; 19(2):705-19. PubMed ID: 20110614 [TBL] [Abstract][Full Text] [Related]
3. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau. Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW J Neurocytol; 2003 Nov; 32(9):1091-105. PubMed ID: 15044841 [TBL] [Abstract][Full Text] [Related]
4. Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model. Ando K; Leroy K; Héraud C; Yilmaz Z; Authelet M; Suain V; De Decker R; Brion JP Am J Pathol; 2011 Feb; 178(2):803-16. PubMed ID: 21281813 [TBL] [Abstract][Full Text] [Related]
5. Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice. Bian F; Nath R; Sobocinski G; Booher RN; Lipinski WJ; Callahan MJ; Pack A; Wang KK; Walker LC J Comp Neurol; 2002 May; 446(3):257-66. PubMed ID: 11932941 [TBL] [Abstract][Full Text] [Related]
6. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Lewis J; McGowan E; Rockwood J; Melrose H; Nacharaju P; Van Slegtenhorst M; Gwinn-Hardy K; Paul Murphy M; Baker M; Yu X; Duff K; Hardy J; Corral A; Lin WL; Yen SH; Dickson DW; Davies P; Hutton M Nat Genet; 2000 Aug; 25(4):402-5. PubMed ID: 10932182 [TBL] [Abstract][Full Text] [Related]
7. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. Higuchi M; Ishihara T; Zhang B; Hong M; Andreadis A; Trojanowski J; Lee VM Neuron; 2002 Aug; 35(3):433-46. PubMed ID: 12165467 [TBL] [Abstract][Full Text] [Related]
9. Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice. Ishizawa T; Sahara N; Ishiguro K; Kersh J; McGowan E; Lewis J; Hutton M; Dickson DW; Yen SH Am J Pathol; 2003 Sep; 163(3):1057-67. PubMed ID: 12937146 [TBL] [Abstract][Full Text] [Related]
10. Tau and axonopathy in neurodegenerative disorders. Higuchi M; Lee VM; Trojanowski JQ Neuromolecular Med; 2002; 2(2):131-50. PubMed ID: 12428808 [TBL] [Abstract][Full Text] [Related]
11. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice. Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886 [TBL] [Abstract][Full Text] [Related]
12. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies. Vingtdeux V; Davies P; Dickson DW; Marambaud P Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377 [TBL] [Abstract][Full Text] [Related]
13. Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia. Planel E; Bretteville A; Liu L; Virag L; Du AL; Yu WH; Dickson DW; Whittington RA; Duff KE FASEB J; 2009 Aug; 23(8):2595-604. PubMed ID: 19279139 [TBL] [Abstract][Full Text] [Related]
14. Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study. Ando K; Kabova A; Stygelbout V; Leroy K; Heraud C; Frédérick C; Suain V; Yilmaz Z; Authelet M; Dedecker R; Potier MC; Duyckaerts C; Brion JP J Alzheimers Dis; 2014; 40 Suppl 1():S135-45. PubMed ID: 24614899 [TBL] [Abstract][Full Text] [Related]
15. Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration. Forman MS; Lal D; Zhang B; Dabir DV; Swanson E; Lee VM; Trojanowski JQ J Neurosci; 2005 Apr; 25(14):3539-50. PubMed ID: 15814784 [TBL] [Abstract][Full Text] [Related]
16. Progressive white matter pathology in the spinal cord of transgenic mice expressing mutant (P301L) human tau. Lin WL; Zehr C; Lewis J; Hutton M; Yen SH; Dickson DW J Neurocytol; 2005 Dec; 34(6):397-410. PubMed ID: 16902761 [TBL] [Abstract][Full Text] [Related]
17. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Yoshiyama Y; Higuchi M; Zhang B; Huang SM; Iwata N; Saido TC; Maeda J; Suhara T; Trojanowski JQ; Lee VM Neuron; 2007 Feb; 53(3):337-51. PubMed ID: 17270732 [TBL] [Abstract][Full Text] [Related]
18. Increased tau phosphorylation but absence of formation of neurofibrillary tangles in mice double transgenic for human tau and Alzheimer mutant (M146L) presenilin-1. Boutajangout A; Leroy K; Touchet N; Authelet M; Blanchard V; Tremp G; Pradier L; Brion JP Neurosci Lett; 2002 Jan; 318(1):29-33. PubMed ID: 11786218 [TBL] [Abstract][Full Text] [Related]
19. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert. Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563 [TBL] [Abstract][Full Text] [Related]
20. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. Ramesh Babu J; Lamar Seibenhener M; Peng J; Strom AL; Kemppainen R; Cox N; Zhu H; Wooten MC; Diaz-Meco MT; Moscat J; Wooten MW J Neurochem; 2008 Jul; 106(1):107-20. PubMed ID: 18346206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]